TREATMENT
Circulating tumor DNA monitoring may guide treatment for metastatic CRC with small lung nodulesIn a 70-patient prospective cohort, ctDNA clearance after treatment was associated with longer progression-free survival (12.6 vs. 6.8 months) and detected extrapulmonary spread a median of 5.5 months before imaging. (Eur J Cancer)